RxDoctor Payments Data

Ashleigh Medda, DPM

Podiatrist · Winston Salem, NCNPI 1477931020

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,094 of the $2,803 with a category attached, or 74.7%. It is spread thinly across 21 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2023 at $1,120 and has fallen 58.0% since, to $470 in 2025.

$2,803in general payments, 2019–2025

Across 41 payments — averaging $68.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Piedmont Plus Innovation$592
  • Organogenesis Inc.$296
  • Polynovo North America LLC$289
  • Arthrex$206
  • Stryker$200
  • Sanara Medtech Inc.$193
  • plus $1K from 15 others

What the payments were for

  • Speaking & faculty fees$1074%
  • Travel & lodging$60221%
  • Food & beverage$2,09475%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,803 in reported general payments places this provider in the 60th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$56,814
Medicare patients
291
Services billed
890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox52$2,221
Ketoconazole15$438
Cephalexin13$109
Mupirocin12$102
Methylprednisolone14$98
Meloxicam39$95

Paid to pharmacies, not to this prescriber.

Other podiatrist in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →